These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 9631153)

  • 1. Highly active antiretroviral therapy in human herpesvirus-8-related body-cavity-based lymphoma.
    Spina M; Gaidano G; Carbone A; Capello D; Tirelli U
    AIDS; 1998 May; 12(8):955-6. PubMed ID: 9631153
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term remission of AIDS-related primary central nervous system lymphoma associated with highly active antiretroviral therapy.
    McGowan JP; Shah S
    AIDS; 1998 May; 12(8):952-4. PubMed ID: 9631151
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic factors in human herpesvirus 8-related lymphoproliferative disorders associated with HIV infection.
    Simonelli C; Tedeschi R; Gloghini A; Spina M; Talamini R; De Paoli P; Tirelli U; Carbone A
    J Clin Oncol; 2006 Jan; 24(1):209; author reply 209-10. PubMed ID: 16382129
    [No Abstract]   [Full Text] [Related]  

  • 4. Solid variant of primary effusion lymphoma in successfully treated HIV infection: a case report.
    Mylona E; Baraboutis IG; Georgiou O; Rondogianni D; Lekakis LJ; Papastamopoulos V; Apostolidis I; Skoutelis AT
    Int J STD AIDS; 2008 Aug; 19(8):570-2. PubMed ID: 18663051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful secondary prophylaxis for primary effusion lymphoma with human herpesvirus 8 therapy.
    Crum-Cianflone NF; Wallace MR; Looney D
    AIDS; 2006 Jul; 20(11):1567-9. PubMed ID: 16847420
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
    Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
    Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.
    Simonelli C; Tedeschi R; Gloghini A; Talamini R; Bortolin MT; Berretta M; Spina M; Morassut S; Vaccher E; De Paoli P; Carbone A; Tirelli U
    J Med Virol; 2009 May; 81(5):888-96. PubMed ID: 19319955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary effusion lymphoma: successful treatment with highly active antiretroviral therapy and rituximab.
    Lim ST; Rubin N; Said J; Levine AM
    Ann Hematol; 2005 Aug; 84(8):551-2. PubMed ID: 15800785
    [No Abstract]   [Full Text] [Related]  

  • 9. HHV8-related non-Hodgkin's lymphoma of the spermatic cord in a patient with HIV-associated multicentric Castleman disease.
    Boulanger E; Brière J; Gaulard P; Droz D; Oksenhendler E
    Am J Hematol; 2003 Jan; 72(1):70-1. PubMed ID: 12508272
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS.
    Boulanger E; Gérard L; Gabarre J; Molina JM; Rapp C; Abino JF; Cadranel J; Chevret S; Oksenhendler E
    J Clin Oncol; 2005 Jul; 23(19):4372-80. PubMed ID: 15994147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease.
    Gabarre J; Marcelin AG; Azar N; Choquet S; Lévy V; Lévy Y; Tubiana R; Charlotte F; Norol F; Calvez V; Spina M; Vernant JP; Autran B; Leblond V
    Haematologica; 2004 Sep; 89(9):1100-8. PubMed ID: 15377471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].
    Tserenpuntsag B; Kołacińska A; Jabłonowska E
    Przegl Epidemiol; 2007; 61(3):529-34. PubMed ID: 18069390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-2, ganciclovir, and high-dose zidovudine for the treatment of AIDS-associated primary central nervous system lymphoma.
    Aboulafia DM
    Clin Infect Dis; 2002 Jun; 34(12):1660-2. PubMed ID: 12032910
    [No Abstract]   [Full Text] [Related]  

  • 14. Spontaneous regression of HIV associated T-cell non-Hodgkin's lymphoma with highly active antiretroviral therapy.
    Fätkenheuer G; Hell K; Roers A; Diehl V; Salzberger B
    Eur J Med Res; 2000 Jun; 5(6):236-40. PubMed ID: 10882638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV viremia and the development of AIDS-related lymphoma in patients treated with highly active antiretroviral therapy.
    Sabin CA
    J Infect Dis; 2009 Jul; 200(1):8-10. PubMed ID: 19476436
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary effusion lymphoma: cytopathologic diagnosis using in situ molecular genetic analysis for human herpesvirus 8.
    Wakely PE; Menezes G; Nuovo GJ
    Mod Pathol; 2002 Sep; 15(9):944-50. PubMed ID: 12218212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated plasmablastic lymphoma.
    Sharma R; Abdou S; Plymyer MR; Rohatgi C
    J Am Coll Surg; 2004 Oct; 199(4):654-5. PubMed ID: 15454154
    [No Abstract]   [Full Text] [Related]  

  • 18. Current status of the treatment of HIV-associated lymphoma.
    Kaplan LD
    Clin Adv Hematol Oncol; 2004 Jan; 2(1):28-9. PubMed ID: 16163156
    [No Abstract]   [Full Text] [Related]  

  • 19. Current treatment strategies for patients with Hodgkin's lymphoma and HIV infection.
    Hartmann P; Rehwald U; Salzberger B; Franzen C; Diehl V
    Expert Rev Anticancer Ther; 2004 Jun; 4(3):401-10. PubMed ID: 15161439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
    Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
    HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.